Page 25 - Read Online

Yanguas-Casás. Neuroimmunol Neuroinflammation 2020;7:13-22 I http://dx.doi.org/10.20517/2347-8659.2019.31 Page 21

49. GAO. Women’s health-FDA needs to ensure more study of gender differences in prescription drug testing. 1992.
50. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis
for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:459-80.
51. Thibaut F. The role of sex and gender in neuropsychiatric disorders. Dialogues Clin Neurosci 2016;18:351-2.
52. Zagni E, Simoni L, Colombo D. Sex and gender differences in central nervous system-related disorders. Neurosci J 2016;2016:2827090.
53. Kopec AM, Smith CJ, Ayre NR, Sweat SC, Bilbo SD. Microglial dopamine receptor elimination defines sex-specific nucleus
accumbens development and social behavior in adolescent rats. Nat Commun 2018;9:3769.
54. McCarthy MM, Pickett LA, VanRyzin JW, Kight KE. Surprising origins of sex differences in the brain. Horm Behav 2015;76:3-10.
55. Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, et al. Incidence of dementia and cognitive impairment, not dementia
in the United States. Ann Neurol 2011;70:418-26.
56. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, et al. Lifetime risk of dementia and Alzheimer’s disease. The impact of mortality on
risk estimates in the Framingham Study. Neurology 1997;49:1498-504.
57. Voskuhl RR, Gold SM. Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 2012;8:255-63.
58. Nolen-Hoeksema S, Girgus JS. The emergence of gender differences in depression during adolescence. Psychol Bull 1994;115:424-43.
59. Altemus M, Sarvaiya N, Neill Epperson C. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol
2014;35:320-30.
60. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, et al. Parkinson’s disease and parkinsonism in a longitudinal study: two-fold
higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000;55:1358-63.
61. Elbaz A, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, et al. Risk tables for parkinsonism and Parkinson’s disease. J Clin
Epidemiol 2002;55:25-31.
62. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-
based study. Neurology 2003;60:813-9.
63. McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med 2010;7:557-70.
64. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord
2003;33:365-82.
65. Hattier MA, Matson JL, Tureck K, Horovitz M. The effects of gender and age on repetitive and/or restricted behaviors and interests in
adults with autism spectrum disorders and intellectual disability. Res Dev Disabil 2011;32:2346-51.
66. Hiller RM, Young RL, Weber N. Sex differences in pre-diagnosis concerns for children later diagnosed with autism spectrum disorder.
Autism 2016;20:75-84.
67. Bálint S, Czobor P, Komlósi S, Mészáros A, Simon V, et al. Attention deficit hyperactivity disorder (ADHD): gender- and age-related
differences in neurocognition. Psychol Med 2009;39:1337-45.
68. Catalá-López F, Peiró S, Ridao M, Sanfélix-Gimeno G, Gènova-Maleras R, et al. Prevalence of attention deficit hyperactivity disorder
among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studies. BMC Psychiatry
2012;12:168.
69. Cole WR, Mostofsky SH, Larson JC, Denckla MB, Mahone EM. Age-related changes in motor subtle signs among girls and boys with
ADHD. Neurology 2008;71:1514-20.
70. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics
2012;9:490-9.
71. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry
2003;60:565-71.
72. Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL. Sex differences in the genetic risk for schizophrenia: history of the evidence
for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet 2013;162B:698-710.
73. Irvine K, Laws KR, Gale TM, Kondel TK. Greater cognitive deterioration in women than men with Alzheimer’s disease: a meta
analysis. J Clin Exp Neuropsychol 2012;34:989-98.
74. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev
2008;30:67-76.
75. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an
amnesic process. Brain 2003;126:770-82.
76. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016;16:626-38.
77. Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X
chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune
response of females. Bioessays 2011;33:791-802.
78. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008;8:737-44.
79. Wang X, Soloway PD, Clark AG. Paternally biased X inactivation in mouse neonatal brain. Genome Biol 2010;11:R79.
80. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400-4.
81. Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol
2018;3.
82. Lehmann SM, Krüger C, Park B, Derkow K, Rosenberger K, et al. An unconventional role for miRNA: let-7 activates Toll-like
receptor 7 and causes neurodegeneration. Nat Neurosci 2012;15:827-35.
83. VanRyzin JW, Marquardt AE, Pickett LA, McCarthy MM. Microglia and sexual differentiation of the developing brain: a focus on
extrinsic factors. Glia 2019.
84. Sierra A, Gottfried-Blackmore A, Milner TA, McEwen BS, Bulloch K. Steroid hormone receptor expression and function in microglia.
Glia 2008;56:659-74.